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Abstract
Background: Combretum zeyheri, belongs to the family Combretaceae and is one of the most popular herbal plants
in tropical and subtropical countries. The leaves of Combretum zeyheri have been used as herbal medicine and have
been reported to have pharmacological activity which includes anti-bacterial, anti-fungal, anticancer and
antioxidant properties. The goal of this study was to isolate, identify and characterize compounds from C. zeyheri
leaves which are responsible for its antifungal activity.
Methods: The preliminary isolation of C. zeyheri active compounds was carried out using chromatographic
techniques which include sephadex gel column chromatography, silica gel column chromatography and thin-layer
chromatography (TLC). The isolated compounds were then investigated for their antifungal activity using broth
dilution assay. The combined effect of the most potent compound and an antifungal drug miconazole was
investigated using the checkerboard assay. Time-kill assays were conducted for the combinations using the colony
counting method. The mechanism of action of 5-hydroxy-7,4’-dimethoxyflavone as a potent antifungal agent was
investigated by determining its inhibitory activity on Candida albicans drug efflux pumps using the ciprofloxacin
assay. The ability of 5-hydroxy-7,4’-dimethoxyflavone to inhibit antioxidant enzymes as well as the biosynthesis of
ergosterol were also investigated.
Results: A total of four pure compounds (A-D) were isolated from C. zeyheri leaf extract. Compound B
(5-hydroxy-7,4’-dimethoxyflavone) was found to be active against Candida albicans using broth dilution method. This
compound was also found to have synergistic activity on growth of C. albicans when combined with miconazole,
completely inhibiting growth after only 4 hrs of incubation. Analysis of ergosterol content from Candida albicans
showed a time-dependent decrease to 91 % and 63 % at 16 and 24 hrs respectively, in cells treated with ½ MIC of
5-hydroxy-7,4’-dimethoxyflavone. The compound 5-hydroxy-7,4’-dimethoxyflavone also showed inhibition of both the
drug efflux pumps (with IC50 = 51.64 μg/ml) and the antioxidant enzymes (at 5 μM).
Conclusion: The compound 5-hydroxy-7,4’-dimethoxyflavone may be partly responsible for the reported antifungal
activity of C. zeyheri, and may serve as a potential source of lead compounds that can be developed as antifungal
phytomedicines.
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Background
Since 1970s, the emergence of antifungal drug resistance
has been a cause of concern in the treatment of invasive
fungal infections such as candidiasis [1]. This is particu-
larly due to increased use of triazoles in prophylactic and
empiric antifungal therapy in high-risk patients [2]. Per-
sons who are at high risk for systemic fungal infections in-
clude those who have haematological malignancies,
undergoing prolonged bone marrow transplantation and
chemotherapy, HIV infected patients and severely burnt
patients [3]. Although many of the antifungal drugs have
advanced the management of fungal infections, failure
rates remain high as the discovery of the ideal antifungal
agent against resistant strains has not been yet obtained
[4, 5]. Thus, there is need for better strategies to protect
existing drugs and develop new classes of effective drugs
to treat resistant infections.
Since 1981, researchers have paid attention to the po-
tential of medicinal plants as alternative sources for the
isolation of novel metabolites with interesting biological
and pharmaceutical properties [6]. Medicinal plants have
been used extensively as crude material or as pure com-
pounds for treating various disease conditions. The
World Health Organization has estimated that almost
65 % of the world’s inhabitants rely mainly on traditional
medicines for their primary health care [7]. This is be-
cause traditional medicine has remained as the most af-
fordable and easily accessible source of treatment in the
primary healthcare system mainly in most developing
countries [8].
In Africa, Combretum species are well known in trad-
itional medicine and used for various ailments and dis-
eases ranging from heart and worm remedies to wound
dressings, treatment of the mentally ill, scorpion stings
and snake bites, to fever and microbial infections [9].
Among antimicrobially active compounds isolated from
Combretum species are combretastatins (bibenzyle com-
pounds), acidic tetracyclic and pentacyclic triterpenes,
ellagitannins, phenanthrenes, flavonoids, saponins and
cycloartane glycosides [10].
We previously reported that Combretum zeyheri had
antifungal activity against C. albicans and C. krusei [11].
It showed growth inhibitory activity against C. albicans
and C. krusei with minimum inhibitory concentrations
of 0.08 and 0.16 mg/ml respectively using the broth dilu-
tion method [10]. Partial bioguided fractionation of C.
zeyheri extract by sephadex LH20 gel column chroma-
tography enabled isolation of the fractions which were
also found to have the antifungal activity as well as the
drug efflux pumps inhibitory activity [12].
Combretum zeyheri has also been reported to have
antimicrobial [10] and antitumor activity [13] as well as
the antioxidant and anti-inflammatory activity [14].
Thus, these previous findings show that C. zeyheri plant
has great antimicrobial potential and may be used as a
source of lead compounds for the development of anti-
microbial drugs. Therefore, the objective of this study
was to isolate the active antifungal compounds from the
crude ethanolic leaf extract of C. zeyheri using chroma-
tographic techniques and then investigate the mechan-
ism of action of these active compounds.
Methods
Fungi and reagents
Reserpine, rhodamine 6G, nutrient agar, sabouraud
dextrose agar (SDA), miconazole, dimethyl sulphoxide
(DMSO), silica gel 60 – 120 mesh, 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),
phenylmethylsulphonyle fluoride (PMSF), sucrose, 1-
chloro-2,4-dinitrobenzene (CDNB), glutathione, hydro-
gen peroxide (H2O2), epinephrine, adrenochrome,
NADPH, EDTA, NaN3, and glucose-6-phosphate were
purchased from Sigma-Aldrich Chemical Co. (St
Louis, MO, USA). The solvents used in this study in-
cluding ethanol, methanol, dichloromethane, ethyl
acetate, petroleum ether, hexane, were of analytical
reagent grade. The water used for all experiments was
of distilled grade. Candida albicans strain ATCC
10231 was a kind gift from Dr. K. Marobela (Depart-
ment of Biological Sciences, University of Botswana).
Plant collection
Combretum zeyheri leaves were collected from Norton
(Geographic coordinates of Norton, Zimbabwe, Latitude:
17°52’59”S, Longitude: 30°42’00”E, Elevation above sea
level: 1360 m, Mashonaland West province of
Zimbabwe). The plant was classified by Mr. Christopher
Chapano, a taxonomist at the National Botanic Gardens
(Harare, Zimbabwe). Herbarium samples (Voucher num-
ber N6E7) were kept at the Department of Biochemistry,
University of Zimbabwe.
Extraction
The preparation of plant extracts was previously de-
scribed [11]. Briefly, 2 kg of C. zeyheri leaves were
ground in a two speed blender (Cole Parmer Instrument
Co., Vernon Hills, USA) and extracted with 8 L of abso-
lute ethanol at room temperature. Extract was filtered
through fine cloth and filtrate was decanted into pre-
weighed labeled container. The solvent was removed
under a stream of air in a fume cupboard at room
temperature. The amount of solid extract was weighed
and recorded.
Isolation of active compounds from Combretum zeyheri
The number of compounds present in C. zeyheri leaf ex-
tract was determined by thin layer chromatography
(TLC). Briefly, a small amount of C. zeyheri plant extract
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was dissolved in dichloromethane and was deposited as a
spot on the TLC plate (aluminium-backed silica gel
60 F254, Sigma Aldrich, St Lous, MO, USA). The bottom
edge of the plate was placed in a solvent reservoir (1 %
methanol in dichloromethane), and the solvent moved up
the plate by capillary action. When the solvent front
reached the other edge of the stationary phase, the plate
was removed from the solvent reservoir. The separated
spots were visualized with ultraviolet lamp at 366 nm and
by placing the plate in iodine vapor. Silica gel column
chromatography was then used to purify individual chem-
ical compounds from mixtures of compounds. For the
assay, a slurry was prepared of the eluent (70 % dichloro-
methane in hexane) with the stationary phase powder
(500 g of silica gel 60–120 mesh, Sigma Aldrich, St Louis,
MO, USA) and then carefully poured into the column
(8 cm internal diameter × 120 cm length). The column
was left overnight to fully pack. The leaf extract of C. zey-
heri (50 g) was adsorbed on 55 g of silica gel and loaded
into the column. This layer was topped with cotton wool
to protect the shape of the organic layer from the velocity
of solvents. Different solvents (70 % dichloromethane in
hexane, 80 % dichloromethane in hexane, 90 % dichloro-
methane in hexane, 100 % dichloromethane, 1 % methanol
in dichloromethane, 2 % methanol in dichloromethane,
3 % methanol in dichloromethane, 5 % methanol in di-
chloromethane) were slowly passed through the column
in order of their increasing polarity, to advance the
organic material. Fractions of 500 ml were collected, va-
porized and compounds present were checked by TLC.
Samples which showed similar TLC profile were com-
bined and further separation carried out using small
columns (2.5 cm internal diameter × 60 cm length). Each
solvent of 500 ml of 50 % dichloromethane in hexane,
60 % dichloromethane in hexane, 70 % dichloromethane
in hexane, 80 % dichloromethane in hexane, 90 % dichlo-
romethane in hexane and 100 dichloromethane was slowly
passed through the column as before to advance the or-
ganic compounds in order of their increasing polarity.
Fractions of 40 ml were collected, vaporized and com-
pounds present were checked by TLC. Fractions which
showed similar TLC profile were combined and further
separation was carried out. For the fractions that showed
presence of 3 or 2 compounds, crystallization was carried
out by adding a few drops of hexane. The crystals formed
were separated by filtration and their purity determined
by TLC. Elucidation and characterization of the structures
of the isolated compounds was carried out using 1H, 13C
NMR techniques and UV spectroscopy.
Antifungal activity determination of the isolated
compounds
The antifungal activity of the C. zeyheri isolated com-
pounds was investigated using the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, as
described before [12]. Cultures of Candida species were
transferred into fresh nutrient broth and 100 μl of fresh
culture were added to each well of a 96-well microtitre
plates. The C. zeyheri isolated compounds were dissolved
in DMSO and added to each well to a final concentration
of 45 μg/ml. Miconazole was used as the positive control
and appropriate solvents used for dissolving the com-
pounds were included as negative controls. Micro plates
were incubated for 24 hours at 37 °C and 100 % relative
humidity. As an indicator of growth 25 μl of 2 mg/ml
MTT was added to each of the microtitre plate wells and
incubated for three hours.
Determination of the effect of combining active
compound with miconazole
The antifungal activity of the isolated compound in com-
bination with miconazole was assessed in a suspension
assay by the checkerboard method. In brief, different con-
centrations of test compound were prepared by serial dilu-
tion and 20 μl of each concentration was added to the
rows of a 96-well microtitre plate in diminishing concen-
trations. The final concentrations of the test compound in
a microtitre plate ranged from 0–90 μg/ml. Miconazole
was also added to the columns to final concentrations of
0–350 μg/ml. A 160 μl suspension of Candida strain
adjusted to 1 × 106 cfu/ml was added to each well and
cultured at 37 °C for 24 hrs. The MIC of the test com-
pound in combination with miconazole was determined
using MTTas described before.
Time-kill assays
The antifungal activities of miconazole and the isolated
active compound alone and in combination against C.
albicans were determined at 0. 4, 8, 20 and 24 hrs of incu-
bation at 37 °C by colony-counting method. Candida albi-
cans was exposed over time to active compound and
miconazole alone as well as to their combinations. Test
solutions were placed on a shaker and incubated at 37 °C.
At the predetermined time point, an aliquot of 20 μl vol-
umes were removed from each test suspension and plated
on SDA for determining the colony forming units. Plates
were then incubated at 37 °C for 24 h in an incubator (Jeio
tech, South Korea) and viable colony counts were per-
formed. The broth (SDB) without any agent was used as
the control for C. albicans growth at each time point.
Determination of the effect of active compounds on drug
efflux pumps
Drug accumulation assays were carried out as described
previously [12], using ciprofloxacin as the standard drug,
to determine the effect of the isolated active compounds
on ABC - drug efflux pumps in C. albicans. Further work
was done to determine the concentration of compound
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that inhibits the activity of drug efflux pumps in C. albi-
cans by half (IC50). IC50 measures the effectiveness of
compound as drug efflux pump inhibitor therefore, differ-
ent concentrations of compound (0–0.07) mg/ml were in-
corporated and the assay procedure was carried out.
Determination of effect of active compound on ergosterol
biosynthesis pathway
The effect of C. zeyheri plant compound on ergosterol
biosynthesis in C. albicans was investigated by quantify-
ing the amount of ergosterol produced by C. albicans in
the presence and absence of the test compound at time
intervals in vitro. Briefly, a single C. albicans colony
from an overnight Sabouraud dextrose agar plate culture
was used to inoculate each of the two flasks containing
400 ml of Sabouraud dextrose broth. The cells were
grown until an OD of 0.5 was reached then C. zeyheri
compound was added to one flask. The cultures were in-
cubated at 37 °C and then 100 ml aliquots were with-
drawn from each flask after 16 hrs and 24 hrs. The cells
were harvested by centrifugation at 1077 × g-force for
5 min and washed once with sterile distilled water. Ten
millilitres of 25 % alcoholic potassium hydroxide solu-
tion (25 g of KOH and 35 ml of sterile water, brought to
100 ml with 100 % ethanol) were added to each pellet
and vortex mixed for 1 min. Cell suspensions were
transferred to sterile tubes and incubated in an 85 °C
water bath for 1 h. Following incubation, tubes were
allowed to cool to room temperature. Sterols were ex-
tracted by adding a mixture of 4 ml sterile water and
10 ml n-hexane followed by vigorous vortex mixing for
3 min. The hexane layer was transferred to a clean tube
and ergosterol content quantified spectrophotometrically
at 293 nm using Unico UV-2800 spectrophotometer
(UNICO United Products and Instruments Inc, Dayton,
United States). The standard curve was used estimate
the concentration of ergosterol produced in the absence
and presence of C. zeyheri plant compound. For stan-
dards preparations, briefly, a stock solution of ergosterol
(0.667 mg/ml) was diluted with ethanol to obtain con-
centrations of 0.01, 0.02, 0.03, 0.04 and 0.05 mg/ml and
absorbances read spectrophotometrically.
Determination of effect of active compound on C.
albicans antioxidant enzymes
Candida albicans cells grown overnight at 37 °C in
the presence of isolated antifungal active compound
(50 μg/ml) were harvested by centrifugation and then
suspended in homogenizing buffer (1 mmol/L phenyl-
methylsulphonyle fluoride, 250 mmol/L sucrose,
10 mmol/L Tris–HCl, pH 7.5). The control sample
was also prepared and did not contain the active
compound. The cells were then mechanically dis-
rupted at 4 °C using a soniprobe (Polytron PT-MR
3000, Kinematica AG, Littau, Switzerland). The
homogenate was collected and centrifuged at 20217 ×
g-force for 1 hour at 4 °C. The supernatant was col-
lected and investigated for its protein concentration
and antioxidant enzyme activity.
Protein determination
The concentration of the antioxidant enzymes produced
in the presence of C. zeyheri antifungal active compound
was determined by the Lowry method [15]. A standard
curve was generated from the concentrations of bovine
serum albumin (BSA) standards and used to find the
concentrations of the samples from their absorbances.
Glutathione-S-transferases
GST activity was determined spectrophotometrically by
measuring the formation of glutathione (GSH) and 1-
chloro-2,4-dinitrobenzene (CDNB) conjugate at 340 nm
[16]. One unit of GST activity is defined as the amount
of enzyme producing 1 μmol of GS-DNB conjugate/min
under the conditions of the assay. In this experiment,
the assay mixture was placed in a 1 mL cuvette and con-
sisted of potassium phosphate buffer pH 6.5 (875 μl),
50 μl of 20 mM glutathione, 50 μl of 20 mM 1-chloro-
2,4-dinitrobenzene (dissolved in ethanol), and 25 and
100 μl of supernatant. The reference cuvette contained
everything except the supernatant being assayed. Results
were expressed as nanomoles CDNB conjugate formed
per minute per milligram protein by using a molar
extinction coefficient of 9.6 × 103 mol.L−1.cm −1.
Catalases
Catalase activity was investigated by measuring the de-
crease in absorbance of H2O2 at 240 nm due to hydro-
gen peroxide decomposition [17]. Potassium phosphate
buffer pH 7.0 (1960 μl), 990 μl of 20 mM H2O2, 50 μl of
supernatant were added to a quartz cuvette. Catalase ac-
tivity was calculated in terms of nanomoles of H2O2
consumed per minute per milligram protein using the
extinction coefficient 0.081 × 10−1 mol.L−1.cm−1. One
unit was defined as 1 μM H2O2 reduced per min.
Superoxide dismutase
Superoxide dismutase activity was determined using the
adrenochrome assay which is based on the ability of
SOD to inhibit the autoxidation of epinephrine in alka-
line [18]. Briefly, during the reaction, SOD reacts with
the O2− formed during the epinephrine oxidation and
therefore slows down the rate of formation of the adre-
nochrome as well as the amount that is formed. Because
of this slowing process, SOD is said to inhibit the oxida-
tion of epinephrine and a unit of SOD activity is defined
as that amount of SOD required to cause 50 % inhibition
of the oxidation of the epinephrine (SOD50). Activity
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was calculated by measuring the increase in absorbance
of the solution containing 50 mM sodium carbonate
buffer pH 10.2 (2685 μl), 75 μl of the supernatant,
200 μM adrenochrome (150 μl) and 90 μl of 0.01 M epi-
nephrine at 480 nm.
Glutathione reductase
Glutathione reductase activity was determined by the
method in which 1 unit of GR activity is defined as the
amount of the enzyme catalyzing the reduction of 1 μM
of NADPH per min [19]. The reaction mixture con-
tained 1.63 ml phosphate buffer pH 7.4, 0.025 ml super-
natant, 0.1 ml NADPH, 0.1 ml EDTA and 0.1 ml
oxidized GSH disulphide. Enzymatic activity was calcu-
lated by measuring the disappearance of NADPH at
340 nm and the results were expressed as nanomoles of
NADPH oxidized per minute per milligram protein.
Glutathione peroxidase
The activity of glutathione peroxidase was determined
by measuring a decrease in absorbance at 340 nm, sug-
gestive of the disappearance of NADPH [20]. The reac-
tion mixture consisted of 1.53 mL phosphate buffer
(0.05 mol/L, pH 7.0), 0.1 mL 1 mmol/L EDTA, 0.1 mL
1 mmol/L NaN3, 0.1 mL 1 mmol/L glutathione (GSH),
0.1 mL 0.2 mmol/L NADPH, 0.01 mL 0.25 mmol/L
H2O2, and 100 μL supernatant in a final volume of
2.0 mL. The reaction was initiated by the addition of
hydrogen peroxide and the enzyme activity was calcu-
lated as nanomoles of NADPH oxidized per minute per
milligram protein by using a molar extinction coefficient
of 6.22 × 103 mol.L−1.cm−1.
Glucose-6-phosphate dehydrogenase
Activity of Glucose-6-phosphate dehydrogenase was de-
termined by measuring the reduction of NADP at
340 nm [21]. The reaction mixture contained 0. 3 ml
Tris-HCI buffer, 0.1 ml NADP, 0.1 ml glucose-6-
phosphate, 0.1 ml MgCI2, 0.02 ml supernatant and
2.38 ml of H2O.
Statistical analysis
A comparison of the antifungal tests and efflux activity
of the samples with the standard efflux inhibitor, reser-
pine was evaluated by applying one way ANOVA using
Dunnet’s Multiple Comparison Test as the post test
which compares the difference between all samples ver-
sus the control sample. All values are expressed as the
mean ± standard deviation and P < 0.05 values or less
were considered to indicate statistically significant differ-
ences. Numerical data were analysed using Graphpad ™
version 5 for Windows, (Graphpad ™ Software Inc., San
Diego, California, USA).
Results
Compounds isolated from Combretum zeyheri
Separation of C. zeyheri plant compounds resulted in 97
different fractions which were then combined according
to their TLC profile similarities (Fig. 1). Further separ-
ation by silica gel column chromatography resulted in
fractions which had 3 or 2 different compounds, accord-
ing to TLC profiles. Compounds were then crystallized
by adding hexane and then filtered through Whatman
paper. Yellow, amorphous solid crystals were observed
in four fractions so they were filtered and purity of the
crystals checked by TLC. Thus, four pure compounds
were isolated from C. zeyheri and were labeled A-D. The
structures of compounds B and C were elucidated using
spectroscopic techniques and were characterized as 5-
hydroxy-7,4’-dimethoxyflavone and 3,5,7-trihydroxyl-
3’,4’-dimethoxyflavone respectively (Fig. 2). 1H NMR
data for 5-hydroxy-7,4’-dimethoxyflavone, or com-
pound B (CDCl3, 400 MHz) was as follows: 12.8 (1H,
s,); 7.78 (2H, dd, 8Hz, 4Hz, H2’ and H6’); 6.97 (2H,
dd, 8Hz, 4 Hz, H3’and H5’); 6.52 (1H, s, H3); 6.43
(1H, d, 4Hz, H8); 6.32 (1H, d, 4Hz, H6); 3.86(3H, s);
3.85 (3H, s).
13C NMR for compound B (CDCl3, 100 MHz): 163.9
(C2), 104.2 (C3), 182.4 (C4), 162.0 (C5), 98.0 (C6), 165.3
(C7), 92.5 (C8), 157.6 (C9), 105.4 (C10), 123.4 (C1’),
127.9 (C2’), 114.4 (C3’), 162.5 (C4’), 114.4(C5’), 127.9
(C6’), 55.8 (C6’– OCH3 ), 55.5(C7 – OCH3).
1H NMR data for 3,5,7-trihydroxyl-3’,4’-dimethoxy-
flavone, or compound C (MeOD, 400 MHz) was as
follows: 12.5 (1H, s,); 7.76 (1H, brs); 7.73 (1H, d, 8Hz);
6.92 (1H, d, 8 Hz); 6.76 (1H, brs); 6.33 (1H, d, 4Hz); 3.84
(3H, s); 3.84 (3H, s).
13C NMR for compound C (MeOD, 100 MHz):
147.4 (C2), 136.6 (C3), 176.4 (C4), 160.7 (C5), 97.9 (C6),
166.3 (C7), 92.5 (C8), 156.5 (C9), 104.4 (C10), 122.3
(C1’), 115.9 (C2’), 147.8 (C3’), 149.4 (C4’), 112.0 (C5’),
122.3 (C6’), 56.5 (C6’– OCH3 ), 56.2 (C7 – OCH3).
Antifungal activity determination of the Combretum
zeyheri isolated compounds
The four compounds that were isolated from C. zeyheri
were tested for their antifungal activity and the results
are shown in Fig. 3. Compound 5-hydroxy-7,4’-
dimethoxyflavone showed antifungal activity against C.
albicans using the broth dilution method [10]. This is
shown by a decrease in growth of the cells as indicated
by a decrease in absorbance when compared to the con-
trol which contained cells only.
Effect of combining 5-hydroxy-7, 4’-dimethoxyflavone
with miconazole
The in vitro combined antifungal activity of 5-hydroxy-
7, 4’-dimethoxyflavone with miconazole against Candida
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albicans was assessed. Results show that 5-hydroxy-7,
4’-dimethoxyflavone in combination with miconazole ex-
hibited severe growth inhibition than miconazole alone
or 5-hydroxy-7, 4’-dimethoxyflavone alone, at all the
concentrations tested (Fig. 4).
Time-kill assays
Synergism was further confirmed with time-kill curves
(Fig. 5). Fungistatic effect on the growth of Candida
cells was observed for both miconazole and 5-
hydroxy-7, 4’-dimethoxyflavone at 150 μg/ml and
22.5 μg/ml respectively. The fungistatic activity of
these two was transformed to fungicidal by combining
them. After only 4 h of incubation, the combination
yielded a decrease to zero colonies in comparison to
miconazole alone.
Effect of 5-hydroxy-7, 4’-dimethoxyflavone on Candida
albicans drug efflux pumps
The compound, 5-hydroxy-7, 4’-dimethoxyflavone was
investigated for its effect on ABC drug transporters in
Candida albicans by measuring the concentration of
ciprofloxacin that accumulated in C. albicans in its
Fig. 1 Typical TLC profile showing different C. zeyheri isolated
fractions with similar compounds. Samples 6, 7 and 8 are different
fractions separated by silica gel column chromatography using 90 %
dichloromethane in hexane. The TLC plate was then run using ethyl
acetate : hexane (1:3) as the mobile phase
Fig. 2 Flavonoids isolated from Combretum zeyheri from Norton,
Mashonaland West, Zimbabwe. The flavonoids were characterized
as 5-hydroxy-7,4’-dimethoxyflavone and 3,5,7-Trihydroxyl-3’,4’-
dimethoxyflavone. These compounds have been isolated before
from other plant species [23–25]
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presence (Fig. 6). Glucose was added to provide energy
for the drug efflux pumps, therefore, cells which were
exposed to glucose only had the least amount of the cip-
rofloxacin that accumulated in cells since the ciprofloxa-
cin was pumped out of the cells. Cells exposed to 5-
hydroxy-7, 4’-dimethoxyflavone retained a higher
amount of ciprofloxacin, thus, indicating the inhibition
of the efflux of the drug from the cells. Reserpine, a
standard inhibitor efflux inhibitor showed the inhibition
of drug efflux as expected. Thus, further work was car-
ried out to determine the concentration of 5-hydroxy-7,
4’-dimethoxyflavone that reduced the percentage activity
of the drug efflux pumps by half, IC50 determination.
The IC50 for 5-hydroxy-7, 4’-dimethoxyflavone was
found to be 51.64 μg/ml (Fig. 7).
Effects of 5-hydroxy-7, 4’-dimethoxyflavone on ergosterol
biosynthesis pathway
Sterol assay was performed for the mechanistic ana-
lysis of the tested drug. Most antifungal drugs target
the ergosterol biosynthesis pathway, particularly the
enzyme lanosterol 14α-demethylase, and disrupt
membrane fluidity, asymmetry and integrity. The ef-
fects of 5-hydroxy-7, 4’-dimethoxyflavone on lanos-
terol 14α-demethylase, was investigated. Figure 8
shows total sterol content of C. albicans treated with
½ MIC of 5-hydroxy-7, 4’-dimethoxyflavone at times
16 and 24 hrs of cell incubation. The compound 5-
hydroxy-7, 4’-dimethoxyflavone showed ergosterol in-
hibition in C. albicans to 91. 6 and 63 % at 16 and
24 hrs respectively, at the tested concentration
(Table 1). The decrease in ergosterol in C. albicans
could be due to slight inhibition of the ergosterol bio-
synthetic pathway. Results from Table 1 show a time-
dependent decrease in ergosterol synthesis as a result
of the effect of 5-hydroxy-7, 4’-dimethoxyflavone.
Effects of 5-hydroxy-7, 4’-dimethoxyflavone on
antioxidant enzymes
Candida albicans has evolved enzymatic antioxidant
defense mechanisms in order to minimise the dam-
aging effects of ROS produced by phagocytes during
an infection, thus 5-hydroxy-7, 4’-dimethoxyflavone
was investigated for its effect on these antioxidant en-
zymes. The activities of the antioxidant enzymes
SOD, CAT, GST, GPx, GR and G6PD were investi-
gated spectrophotometrically by measuring change in
absorbance of samples in the presence or absence of
the compound 5-hydroxy-7,4’-dimethoxyflavone. Spe-
cific activities of antioxidant enzymes were then cal-
culated using the extinction coefficients provided for
each enzyme and results recorded in Table 2. Results
show that 5 μM of 5-hydroxy-7,4’-dimethoxyflavone
resulted in complete inhibition of activity of the en-
zymes superoxide dismutase, glutathione peroxidase,
glutathione reductase, glutathione-S-transferase and
glucose-6-phosphate dehydrogenase. However, treating
Candida albicans with 5-hydroxy-7,4’-dimethoxyfla-
vone resulted in roughly a 26 % decrease in activity
of the enzyme catalase.
Fig. 3 Effect of C. zeyheri compounds on growth of C. albicans.
Generally a decrease in growth of cells was observed in the
presence of Compound B, C. zeyheri extract and the standard
inhibitor miconazole. The results are comparable to media only,
where no cells were added. Values are mean ± SD for N = 3
and *P < 0.0001
Fig. 4 Synergistic activity of 5-hydroxy-7,4’-dimethoxyflavone-micon-
azole mixture against C. albicans. (A – 22. 5 μg/ml compound B, B –
90 μg/ml compound B, C – 150 μg/ml Miconazole, D – 150 μg/ml
Miconazole + 22.5 μg/ml compound B, E - 150 μg/ml Miconazole +
90 μg/ml compound B.) Values are mean ± SD for N = 3. Complete
inhibition of growth of C. albicans was observed when 5-hydroxy-
7,4’-dimethoxyflavone and miconazole were combined, unlike when
the two were tested on their own
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Discussion
Plants have been reported as a valuable source of new nat-
ural products despite the availability of different ap-
proaches for the discovery of therapeutics. Studies
involving the isolation, characterization and purification of
the chemical compounds of the plant and screening for
antifungal activity have been reported to be more than
promising [22]. The assumption for these studies was that
they may result in the development of a potent entity
which will be of lower toxicity and a high therapeutic
value to mankind. In this current study, the air-dried
leaves of C. zeyheri were extracted successively with etha-
nol followed by various chromatographic techniques using
different solvents. Subsequent chromatographic assays on
silica gel yielded compounds 5-hydroxy-7, 4’-dimethoxy-
flavone and 3, 5, 7-trihydroxyl-3’, 4’-dimethoxyflavone
(Fig. 2). The compounds were investigated for their anti-
fungal activity and 5-hydroxy-7, 4’-dimethoxyflavone was
found to have an MIC of 45 μg/ml against C. albicans
(Fig. 3). This is the first time that the antifungal activity of
5-hydroxy-7, 4’-dimethoxyflavone against C. albicans has
been reported using the broth dilution assay. The com-
pound 5-hydroxy-7,4’-dimethoxyflavone has already been
discovered in the methanol extract of aerial parts of Salvia
poculata Nab., a Turkish endemic Salvia species [23] and
had showed antioxidant activity using β-carotene bleach-
ing, and superoxide anion radical and 2,2’-azino-bis(3-eth-
ylbenzothiazoline-6-sulphonic acid (ABTS) cation radical
Fig. 5 Representative time-kill curves of Candida albicans following exposure to miconazole, Compond B (5-hydroxy-7,4’-dimethoxyflavone) and
miconazole combined with Compound B. Control represents the untreated Candida cells. There was decrease on the rate at which the Candida
cells treated with 5-hydroxy-7,4’-dimethoxyflavone-Miconazole mixture were growing as compared to the untreated cells and those treated with
miconazole alone or 5-hydroxy-7,4’-dimethoxyflavone alone
Fig. 6 Graph showing the concentrations of ciprofloxacin that
accumulated in C. albicans in the presence of glucose only, DMSO,
reserpine and compound B. Values are mean ± SD for N = 3 and *P <
0.05. Cells which were exposed to glucose had the least amount of the
ciprofloxacin left in the cells, thus, indicating active efflux with glucose
serving as a source of energy. Cells exposed to glucose and 5-hydroxy-
7,4’-dimethoxyflavone had a higher amount of dye, thus, indicating the
inhibition of the efflux of the ciprofloxacin from the cells. Reserpine, a
standard inhibitor efflux inhibitor showed the inhibition of drug efflux
and DMSO was the negative control and solvent used to dissolve the
compound 5-hydroxy-7, 4’-dimethoxyflavone
Fig. 7 Determination of IC50 for Compound B on C. albicans’ efflux
pumps inhibitory activity. Values are mean ± SD for N = 3. The IC50
for Compound B was found to be 51.64 μg/ml
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scavenging activity assays. The compound 5-hydroxy-7,
4’-dimethoxyflavone has also been isolated from Combre-
tum erythrophylum and was found to have antimicrobial
activity against Vibrio cholerae and Enterococcus faecalis,
with MIC values ranging from 25–50 μg/ml [24]. How-
ever, the same study found it to be toxic to human cells
and to have the poorest antioxidant activity. In another
study, 5-hydroxy-7, 4’-dimethoxyflavone was isolated from
the rhizome of Kaempferia parviflora,which has been used
for the treatment of allergy and gastrointestinal disorders
as well as an aphrodisiac and for fungal infections [25].
However, this compound was found to have no antifungal
activity against the dermatophytes Trichophyton rubrum,
Trichophyton mentagrophytes and Microsporum gypseum
at the highest concentration of 250 μg/ml tested. The an-
tifungal activity of this compound was not investi-
gated against C. albicans in this same study.
Therefore, this current study reports the successful
isolation of 5-hydroxy-7, 4’-dimethoxyflavone from C.
zeyheri leaf extract, which we previously reported to
have antifungal activity [11].
Further work was carried out to determine the com-
bined activity of 5-hydroxy-7, 4’-dimethoxyflavone with
miconazole since synergism has become a possible
thrust area in developing therapeutic strategies against
infectious diseases. The results demonstrated that 5-
hydroxy-7,4’-dimethoxyflavone is very effective as anti-
fungal agent, as it inhibited C. albicans at 22.5 μg/ml
and showed synergy with miconazole as shown by a de-
crease in growth of C. albicans cells in the presence of
5-hydroxy-7,4’-dimethoxyflavone-miconazole mixture as
compared to 5-hydroxy-7,4’-dimethoxyflavone alone or
miconazole alone (Figs. 4 and 5). Thus, the efficacy of
antifungal agents can be improved by using combination
therapy where these drugs are administrated along with
other chemosensitizing agents.
The isolated 5-hydroxy-7, 4’-dimethoxyflavone was
further investigated for its inhibitory activity on ABC
drug efflux pumps in C. albicans by monitoring an in-
crease in ciprofloxacin, assessing the level of its accumu-
lation, in response to reserpine. There was a higher
accumulation of ciprofloxacin in Candida cells in the
presence of 5-hydroxy-7, 4’-dimethoxyflavone than with
reserpine (Fig. 6). The compound 5-hydroxy-7, 4’-
dimethoxyflavone demonstrated the activity in a dose-
dependent manner with IC50 value of 51.64 μg/ml
(Fig. 7). These results support those obtained from
synergism assays where by the underlying synergistic an-
tifungal mechanisms could be due to blockage of ABC
efflux pumps and increasing the susceptibility of Can-
dida to miconazole. Further work would be necessary to
establish the major mechanism which could be competi-
tive inhibition of drug efflux pumps or non competitive
inhibition. It also would be of great interest to determine
whether or not 5-hydroxy-7, 4’-dimethoxyflavone can in-
hibit the activity of other Candida drug transporters
such as CaMdr1p belonging to major facilitator super-
family. The study of inhibitors of the drug efflux pumps
in Candida species is of great importance but to date
only limited in vivo testing has been done and no human
toxicology of promising candidates has been performed
[26]. The challenges that have so far been reported in-
clude that the search for candidate efflux pump inhibi-
tors can be costly and time consuming since substantial
efforts are needed before inhibitors of efflux pumps can
be used clinically and be fully accepted by the medical
community.
This study also focused on investigating the effect of
the 5-hydroxy-7, 4’-dimethoxyflavone on the C. albicans
ergosterol biosynthesis. Ergosterol biosynthesis is an im-
portant target for the development of novel antimycotic
drugs, and that of C. albicans has been proposed with
14 sterol intermediates resulting in ergosterol and an-
other secondary final compound C-24 ethylsterol [27].
Classes of antimycotics that are curently used to target
the ergosterol biosynthesis pathway and disrupt mem-
brane fluidity, asymmetry and integrity are the azoles,
allylamines, polyenes, and morpholines [28]. Analysis of
Fig. 8 Effect of production of ergosterol by C. albicans in the
presence and absence of Compound B at times 16 and 24 hours.
Values are mean ± SD for N = 3 and *P < 0.05. A decrease in
ergosterol produced by C. albicans in the presence of 5-hydroxy-7,4’-
dimethoxyflavone was observed with time
Table 1 Time-dependent effect of 5-hydroxy-7,4’-dimethoxyfla-
vone on ergosterol production by C. albicans
Time of incubation (hrs) [Ergosterol] % decrease
16 91.6
24 63.0
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ergosterol obtained from tested Candida albicans
showed a time-dependent decrease to 91 % and 63 % at
16 and 24 hrs respectively, in ergosterol content in the
cells treated with ½ MIC of 5-hydroxy-7, 4’-dimethoxy-
flavone (Fig. 8 and Table 1). This study supports the
work which previously showed that most of the ergos-
terol inhibitors were fungicidal in its action [29]. This
could be due to direct damage to the cell membrane.
However, the exact mode of action 5-hydroxy-7, 4’-
dimethoxyflavone need to be elucidated. Further studies
with a higher number of azole-resistant strains should
help elucidate whether 5-hydroxy-7, 4’-dimethoxyflavone
maintains a good level of activity in all cases. If this is
the case, 5-hydroxy-7, 4’-dimethoxyflavone, alone or in
combination with azoles, could represent an alternative
for the treatment of C. albicans infections.
Antioxidant enzymes have a role in the protection of
C. albicans against oxidative stress, thus, inhibition of
these enzymes by 5-hydroxy-7, 4’-dimethoxyflavone may
be a step toward the search for new targets for antifun-
gal agents. The results obtained in this study showed
complete inhibition of the activity for all the enzymes
tested except for catalase which showed a decreased ac-
tivity in the presence of 5-hydroxy-7, 4’-dimethoxyfla-
vone (Table 2). However, observed decrease in specific
activity or complete inhibition of activity may not be due
to direct effects of the compound on enzymes because
previously, 5-hydroxy-7,4’-dimethoxyflavone has been
reported to have an antioxidant activity, thus, may have
quenched the reactive oxygen species before C. albicans
produced antioxidant enzymes [23].
Conclusion
The compound responsible for the antifungal activity of
the leaf extract of Combretum zeyheri was successfully
isolated and characterized as 5-hydroxy-7, 4’-
dimethoxyflavone.
The mechanism of action of 5-hydroxy-7, 4’-dimethox-
yflavone as an antifungal includes inhibition of C. albi-




SDA: Sabouraud dextrose agar; MIC: Minimum inhibitory concentration;
TLC: Thin layer chromatography; ABC: ATP binding cassette; OD: Optical
density; BSA: Bovine serum albumin; ATCC: American type culture cell;
CDNB: 1-Chloro-2,4-dinitrobenzene; DMSO: Dimethyl sulfoxide;
EDTA: Ethylenediaminetetraacetic acid; IC50: Half maximal inhibitory
concentration; SOD: Superoxide dismutase; GST: Glutathione-s-transferase;
CAT: Catalase; GR: Glutathione reductase; G6PD: Glucose 6 phosphate
dehydrogenase; GPx: Glutathione peroxidase; GSH: Glutathione;
NADP: Nicotinamide adenine dinucleotide phosphate; H2O2: Hydrogen
peroxide.
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